BR112023003792A2 - Derivados de sulfamoil ureia contendo porção alquil-oxacicloalquila e usos dos mesmos - Google Patents
Derivados de sulfamoil ureia contendo porção alquil-oxacicloalquila e usos dos mesmosInfo
- Publication number
- BR112023003792A2 BR112023003792A2 BR112023003792A BR112023003792A BR112023003792A2 BR 112023003792 A2 BR112023003792 A2 BR 112023003792A2 BR 112023003792 A BR112023003792 A BR 112023003792A BR 112023003792 A BR112023003792 A BR 112023003792A BR 112023003792 A2 BR112023003792 A2 BR 112023003792A2
- Authority
- BR
- Brazil
- Prior art keywords
- oxacycloalkyl
- motion
- containing alkyl
- urea derivatives
- derivatives containing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Neurosurgery (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063074521P | 2020-09-04 | 2020-09-04 | |
| PCT/US2021/049001 WO2022051582A1 (en) | 2020-09-04 | 2021-09-03 | Sulphamoyl urea derivatives containing alkyl-oxacycloalkyl moiety and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112023003792A2 true BR112023003792A2 (pt) | 2023-03-28 |
Family
ID=77951864
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112023003792A BR112023003792A2 (pt) | 2020-09-04 | 2021-09-03 | Derivados de sulfamoil ureia contendo porção alquil-oxacicloalquila e usos dos mesmos |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20240043410A1 (https=) |
| EP (1) | EP4208459A1 (https=) |
| JP (1) | JP2023540733A (https=) |
| KR (1) | KR20230061505A (https=) |
| CN (1) | CN116783184A (https=) |
| AR (1) | AR123435A1 (https=) |
| AU (1) | AU2021336518A1 (https=) |
| BR (1) | BR112023003792A2 (https=) |
| CA (1) | CA3191410A1 (https=) |
| IL (1) | IL301055A (https=) |
| MX (1) | MX2023002686A (https=) |
| WO (1) | WO2022051582A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201721185D0 (en) | 2017-12-18 | 2018-01-31 | Nodthera Ltd | Sulphonyl urea derivatives |
| CN114641466B (zh) | 2019-06-12 | 2025-09-30 | 诺瑟拉有限公司 | 磺酰脲衍生物及其用途 |
| WO2025104244A1 (en) * | 2023-11-17 | 2025-05-22 | NodThera Limited | Methods of preparing urea derivatives |
| WO2025104268A1 (en) | 2023-11-17 | 2025-05-22 | NodThera Limited | Forms of urea derivatives and related uses |
| WO2025153532A1 (en) * | 2024-01-16 | 2025-07-24 | NodThera Limited | Nlrp3 inhibitors and glp-1 agonists combination therapies |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| US5763263A (en) | 1995-11-27 | 1998-06-09 | Dehlinger; Peter J. | Method and apparatus for producing position addressable combinatorial libraries |
| AU723895B2 (en) | 1997-01-29 | 2000-09-07 | Pfizer Inc. | Sulfonyl urea derivatives and their use in the control of interleukin-1 activity |
| KR102727059B1 (ko) * | 2015-02-16 | 2024-11-05 | 더 유니버서티 어브 퀸슬랜드 | 설포닐우레아와 관련 화합물 및 그 용도 |
| RS65492B1 (sr) | 2017-07-24 | 2024-05-31 | Novartis Ag | Jedinjenja i kompozicije za lečenje stanja povezanih sa aktivnošću nlrp |
| GB201721185D0 (en) * | 2017-12-18 | 2018-01-31 | Nodthera Ltd | Sulphonyl urea derivatives |
| US12187702B2 (en) * | 2018-08-15 | 2025-01-07 | Inflazome Limited | Sulfonamideurea compounds |
-
2021
- 2021-09-03 CN CN202180074301.7A patent/CN116783184A/zh active Pending
- 2021-09-03 EP EP21778667.2A patent/EP4208459A1/en active Pending
- 2021-09-03 AU AU2021336518A patent/AU2021336518A1/en active Pending
- 2021-09-03 CA CA3191410A patent/CA3191410A1/en active Pending
- 2021-09-03 MX MX2023002686A patent/MX2023002686A/es unknown
- 2021-09-03 WO PCT/US2021/049001 patent/WO2022051582A1/en not_active Ceased
- 2021-09-03 AR ARP210102472A patent/AR123435A1/es unknown
- 2021-09-03 JP JP2023514910A patent/JP2023540733A/ja active Pending
- 2021-09-03 US US18/043,883 patent/US20240043410A1/en active Pending
- 2021-09-03 IL IL301055A patent/IL301055A/en unknown
- 2021-09-03 BR BR112023003792A patent/BR112023003792A2/pt unknown
- 2021-09-03 KR KR1020237011396A patent/KR20230061505A/ko active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2022051582A1 (en) | 2022-03-10 |
| KR20230061505A (ko) | 2023-05-08 |
| CA3191410A1 (en) | 2022-03-10 |
| CN116783184A (zh) | 2023-09-19 |
| TW202229265A (zh) | 2022-08-01 |
| IL301055A (en) | 2023-05-01 |
| AR123435A1 (es) | 2022-11-30 |
| AU2021336518A1 (en) | 2023-03-23 |
| US20240043410A1 (en) | 2024-02-08 |
| JP2023540733A (ja) | 2023-09-26 |
| MX2023002686A (es) | 2023-04-03 |
| EP4208459A1 (en) | 2023-07-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112023003792A2 (pt) | Derivados de sulfamoil ureia contendo porção alquil-oxacicloalquila e usos dos mesmos | |
| MX2020006399A (es) | Derivados de sulfonil urea. | |
| ZA202000425B (en) | Selective inhibitors of nlrp3 inflammasome | |
| PH12021550166A1 (en) | Nlrp3 inflammasome inhibitors | |
| ECSP21080740A (es) | Inhibidores del inflamasoma nlrp3 | |
| WO2004071400A3 (en) | Histone deacetylase inhibitors of novel benzamide derivatives with potent differentiation and anti-proliferation activity | |
| EA201992152A1 (ru) | Химические соединения | |
| PE20240881A1 (es) | Uso de un inhibidor de la ezh2 en la preparacion de farmacos para el tratamiento del linfoma de linfocitos t | |
| WO2020185928A1 (en) | Charged ion channel blockers and methods for use | |
| BR112022012684A2 (pt) | Compostos cíclicos e métodos de uso dos mesmos | |
| MX2023002547A (es) | Compuestos novedosos como inhibidor de histona desacetilasa 6 y composicion farmaceutica que comprende los mismos. | |
| JOP20220281A1 (ar) | مركبات وتركيبات لتثبيط نشاط hif2 ألفا وطرق لاستخدامها | |
| DOP2025000013A (es) | Inhibidores de inflamasoma nlrp3 | |
| CL2021003034A1 (es) | Métodos de tratamiento del síndrome de sjögren utilizando un inhibidor de la tirosina quinasa de bruton | |
| MX2024014315A (es) | Compuestos amido heteroaromaticos utiles en el tratamiento de enfermedades hepaticas | |
| MX2022015524A (es) | Formas cristalinas del acido {2-[3-ciclohexil-3-(trans-4-propoxi-c iclohexil)-ureido]-tiazol-5-ilsulfanil}-acetico y uso de las mismas. | |
| CO2025014389A2 (es) | Derivados de amida para inhibir nlrp3 y usos de estos | |
| MX2025011886A (es) | Derivados biciclicos semisaturados y usos relacionados | |
| MX2025003934A (es) | Métodos para preparar derivados de carbamato | |
| MX2021008930A (es) | Derivados de carbamato y sus usos. | |
| CO2025007987A2 (es) | Derivados de tiadiazol como inhibidores de la sintasa de gmp-amp cíclico y usos de los mismos | |
| JP7752870B2 (ja) | 発毛を誘導するためのイタコネートおよびその誘導体/類似体の使用 | |
| BR112023002082A2 (pt) | Síntese de derivados de imipridona e sua avaliação para sua atividade anticancerígena | |
| MX2024008477A (es) | Derivados biciclicos de ftalazina-1(2h)-ona y usos relacionados. | |
| MX2022015532A (es) | Inhibidores selectivos de hdac6 y usos de los mismos. |